Format
Deep dives
Comprehensive, foundational pieces on a topic.
40 articles
Mitochondrial healthAMPK — the cellular energy sensor and why metformin became a longevity drugMetformin has been prescribed to people with type 2 diabetes since the 1950s in Europe and since 1995 in the United States. It is among the most prescribed drugs in the world, with a safety profile that decades of clinical use have established as genuinely good. For most of that time, nobody fully understood how it worked. The pharmacological mechanism — what it was actually doing in the cell to lower blood glucose — was the subject of debate for more than forty years. The explanation, when it arrived in the early 2000s, turned out to be more interesting than a diabetes mechanism. It pointed at a kinase that sits at the center of cellular energy sensing, and through that kinase it connected metformin to a biology that reaches from mitochondria to mTOR to lifespan.11 min readAnti-aging and cellular healthAutophagy — the cellular cleanup system that aging depends onYoshinori Ohsumi's laboratory in Tokyo was not working on aging. In the early 1990s, he was a cell biologist studying vacuoles — the storage compartments of yeast cells — using a relatively simple experimental approach: starve the yeast, then look at the vacuoles under a microscope and see what happens. What happened, in cells he had genetically engineered to prevent the breakdown of what accumulated there, was that the vacuoles filled with tiny spherical structures. The structures were coming from the cytoplasm. The cell was packaging pieces of itself and delivering them to the vacuole for digestion. Ohsumi had found, and then systematically characterized, the genetic machinery underlying a process that had been glimpsed in electron micrographs since the 1960s but had never been cracked at the molecular level. He called it autophagy — from the Greek for self-eating — and in 2016 he received the Nobel Prize in Physiology or Medicine for the discovery that this cellular self-digestion was not aberrant but exquisitely regulated, essential for survival under stress, and implicated in diseases from cancer to neurodegeneration to aging itself.12 min readCognitive supportBDNF — the brain growth factor that links exercise to cognitionIn the early 1990s, researchers at the Salk Institute were trying to understand why running wheels in rat cages did anything to the brain at all. The behavioral observation was already established — rats with access to running wheels performed better on maze tasks, showed better stress resilience, had measurably different neural architecture in the hippocampus. The question was mechanism. What was happening in the tissue that exercise could possibly cause? The answer they kept arriving at was a protein that most of the neuroscience community hadn't been thinking much about: brain-derived neurotrophic factor.11 min readCognitive supportBDNF and the exercising brain — the neurotrophin that links movement to memoryIn 1982, a German neuroscientist named Yves-Alain Barde, working with Hans Thoenen at the Max Planck Institute, purified a tiny amount of a protein from pig brain that could keep certain neurons alive in a dish — neurons that would otherwise have died. It was a painstaking effort; the protein was present in vanishingly small quantities, and isolating enough to characterize took the better part of a decade of refinement. They named it brain-derived neurotrophic factor. At the time it looked like a narrow curiosity: a second member of a small family of survival factors, the first of which, nerve growth factor, had won Rita Levi-Montalcini and Stanley Cohen the Nobel Prize. What no one fully anticipated was that this second molecule would turn out to be one of the most important signals in the brain — the molecular bridge between how the body moves and how the mind learns, remembers, and feels.8 min readImmune modulationThe cathelicidin / antimicrobial peptide story — why the body makes its own antibioticsIn 1928, Alexander Fleming noticed that a mold contaminating one of his bacterial cultures had cleared the bacteria around it. The compound the mold produced — penicillin — became the foundation of modern antibiotics, and for decades afterward, pharmaceutical companies found new antibiotics fast enough that the ones bacteria learned to defeat could be replaced by the ones bacteria hadn't encountered yet. That era is over. The pipeline of genuinely novel antibiotic chemical classes has slowed to a trickle. The bacteria, meanwhile, have not slowed.10 min readAnti-aging and cellular healthCellular senescence in deeper detail — the biology, biomarkers, and intervention frontierA cell under severe stress faces a choice. It can repair the damage and carry on. It can trigger apoptosis — the orderly self-destruction program that eliminates compromised cells cleanly. Or it can do something else: it can stop dividing, enlarge, change its behavior, and stay. This third option is cellular senescence, and for decades it was understood primarily as a tumor suppression mechanism — a way of permanently halting cells that might otherwise accumulate mutations and turn cancerous. That understanding was correct as far as it went. What took longer to recognize was the cost.12 min readSleep and recoveryThe chronobiology of aging — how time-of-day biology shifts across decadesIn October 2017, the Nobel Committee awarded its Prize in Physiology or Medicine to three American scientists — Jeffrey Hall, Michael Rosbash, and Michael Young — for work they had been doing since the 1980s in fruit flies. The work seemed, at the time, like beautiful basic science. They had identified the molecular machinery that makes biological clocks tick: not just the observation that living things have circadian rhythms, but the actual gears — the genes, the proteins, the feedback loops that generate a 24-hour oscillation at the cellular level. The prize recognized that this machinery is conserved across nearly all forms of life, that it is present in every human cell, and that its disruption underlies an array of conditions whose connection to time-of-day biology had not previously been obvious: metabolic disease, cancer risk, neurodegeneration, immune dysfunction, mood disorders.12 min readSleep and recoveryClock genes and the molecular machinery of circadian rhythmsIn 1971, a Caltech neurobiologist named Seymour Benzer and his student Ronald Konopka did something that looked, at the time, like a footnote. They exposed fruit flies — Drosophila melanogaster — to a chemical mutagen and then watched what happened to the flies' behavior. Normal flies follow a precise 24-hour activity rhythm: active during the day, inactive at night, eclosing from their pupal cases at a consistent circadian time. Some of the mutant flies lost this rhythm entirely. Others ran on 19-hour cycles. Others ran on 28-hour cycles. Benzer and Konopka mapped all three behavioral mutations to the same genetic locus, which they named period. It was the first identification of a gene controlling behavior — a gene that, when altered, didn't change what the animal did but when it did it.11 min readOrigins and discoveryThe neuropeptide universe — from Semax and Cortexin to Dihexa, the cognitive enhancement field that doesn't show up in US pharmaIn 1972, a Soviet neuropharmacologist named Nikolai Koval published early research on neuropeptide fragments derived from ACTH — adrenocorticotropic hormone — and their effects on memory and learning in animal models. He was not working in a vacuum. Across Soviet research institutes, the emerging field of neuropeptide biology was being pursued with particular intensity, partly because it offered a theoretical alternative to the receptor-agonist pharmacology dominating Western drug development, and partly because Soviet research programs were structured around different institutional priorities, different funding pressures, and different timelines than their Western counterparts. The compounds that emerged from that tradition — Semax, Selank, Cortexin, Cortagen, Pinealon, and others — are now used clinically in Russia and parts of Eastern Europe. In the United States, most physicians have never heard of them.9 min readAnti-aging and cellular healthExosomes and extracellular vesicles — the cell-to-cell communication system you didn't learn aboutIn 1983, two separate research groups — one in Montreal, one in Boston — were studying how developing red blood cells dispose of their transferrin receptors as they mature. The cell needed to get rid of certain surface proteins. They watched it do something unexpected: instead of simply degrading the receptors, the cell packaged them into tiny membrane-bound bubbles and released them into the surrounding fluid. The bubbles were assumed to be waste. Cellular garbage bags. The researchers noted the finding, named the vesicles, and moved on. Nobody thought this was a communication system. Nobody thought it was going to matter.12 min readAnti-aging and cellular healthFOXO transcription factors — the longevity nodes you didn't learn aboutIn 1993, a graduate student named Cynthia Kenyon made a worm live twice as long. The organism was Caenorhabditis elegans, the one-millimeter nematode that had become molecular biology's favorite model because its entire nervous system — 302 neurons — is mapped, its genome is sequenced, and its lifespan, normally around three weeks, is short enough to run multiple generations of aging experiments in a semester. Kenyon's lab found that a single mutation in a gene called daf-2 doubled the worm's lifespan. Not extended it modestly. Doubled it. The worm also remained healthier for longer — more active, more stress-resistant, physiologically younger at the midpoint of its extended life than normal worms were at their natural endpoint. The finding was so extreme that the field initially questioned whether it was real.11 min readAnti-aging and cellular healthGDF11 and GDF15 — the controversial aging factors discovered in young bloodThe experiment looked like science fiction when it first appeared in the literature, though the technique was nearly a century old. Parabiosis — surgically joining two animals so that they share a circulatory system — had been used intermittently since the 1950s to study blood-borne factors. What Tom Rando's lab at Stanford and Amy Wagers's lab at Harvard were doing in the mid-2000s was pairing old mice with young ones and asking what happened. What happened was striking. Old mice connected to young circulatory systems showed improvements in muscle regeneration, liver function, and in some paradigms, brain physiology. Young mice connected to old circulatory systems showed the reverse — accelerated deterioration of some measures. The implication was immediate and difficult to dismiss: something in the blood of young animals was promoting tissue maintenance, and something in the blood of old animals was impairing it. The factors responsible were unknown. Finding them became one of the more intensely pursued objectives in aging biology.11 min readAnti-aging and cellular healthGene expression and tissue specificity — why the same genome makes different cellsIn 1962, a British developmental biologist named John Gurdon did something that shouldn't have been possible according to the consensus of the day. He took the nucleus of a fully differentiated intestinal cell from an adult frog, transplanted it into an enucleated frog egg, and watched it develop into a functioning tadpole. The experiment was technically difficult, widely doubted, and conceptually unsettling, because it implied something that the field hadn't fully accepted: differentiated cells don't lose genetic information when they specialize. The intestinal cell's nucleus contained everything needed to build a complete organism. Every cell type, throughout the frog's body, carried the full complement of genetic instructions. They just used different parts of it.12 min readMetabolic healthGlycation and AGEs — the sugar-driven aging mechanismWhen a pathologist examines the aorta of someone who died of cardiovascular disease, one of the things they look at is the compliance of the vessel wall — how much it stretches under pressure. In a young, healthy aorta, the wall is elastic; it expands with the pulse and recoils between beats, absorbing and releasing energy like a spring. In an aged or diseased aorta, the wall is stiff. It doesn't give. The left ventricle has to work harder to push against it, and blood pressure rises. The structural difference between the two vessels, in large part, comes down to chemistry that began accumulating years or decades before the heart failure or the stroke or the aneurysm made the stiffness clinically apparent.7 min readImmune modulationThe gut-brain axis — bidirectional signaling in plain EnglishThe deadline arrives and your gut goes wrong. Not metaphorically — actually. The night before a high-stakes presentation your stomach churns, your bowels shift, and the stress you experience as something cognitive and psychological has already moved through your body and changed how your intestines are behaving. Most people recognize this version of the connection. What they don't know is that the road runs both ways, and the traffic in the other direction is heavier.9 min readImmune modulationThe gut microbiome and aging — what changes and why it mattersIn a study published in Nature in 2021, researchers followed a cohort of people aged 18 to 101 and found something they hadn't entirely expected: in the oldest, healthiest individuals — the ones who were living well past 80 with minimal functional decline — the gut microbiome was distinctively and measurably different from the microbiome of age-matched people who were aging less well. The long-lived group had higher microbial diversity. They had more of certain bacterial species that produce beneficial metabolites. Their gut communities looked, in some ways, more like the communities found in younger healthy adults than like those of their struggling contemporaries.8 min readAnti-aging and cellular healthThe Hayflick limit and telomerase — why cells stop dividing, and why that's complicatedIn the late 1950s, the prevailing belief among cell biologists was that cells grown in culture were, in principle, immortal. The authority for that view was Alexis Carrel, a Nobel laureate who claimed to have kept a culture of chick heart cells dividing continuously for decades — long past the lifespan of any chicken. The conclusion drawn from Carrel's famous experiment was that cells did not age; only the organism did, and any limit on a cell's lifespan in a dish must be a failure of technique. Then a young anatomist named Leonard Hayflick, working at the Wistar Institute in Philadelphia, started paying close attention to his own cultures of human fibroblasts and noticed something Carrel's dogma did not predict. The cells divided vigorously, then slowed, then stopped. Every time. No matter how perfect the culture conditions.8 min readHormonal and endocrineThe HPO axis — and the peptides that regulate itThe pituitary gland sits in a bony depression at the base of the skull, connected by a slender stalk to the hypothalamus above it. The connection looks almost accidental — a short tube between two adjacent brain structures. But the chemical conversation that travels through that stalk, and down through the bloodstream to the ovaries or testes and back again, is the regulatory circuit that governs human reproduction, sexual development, and a significant portion of metabolic function. Understanding that circuit — the hypothalamic-pituitary-gonadal axis, and specifically its ovarian variant, the HPO axis — is the foundational requirement for making sense of a wide class of hormonal problems, fertility interventions, and the peptide pharmacology that targets it.8 min readImmune modulationInflammaging — the chronic low-grade inflammation that drives agingIn 2000, an Italian immunologist named Claudio Franceschi published a paper that changed how aging biology thinks about its central problem. Franceschi had spent years studying centenarians — people who had reached one hundred years and beyond — and what he noticed was not just that they had survived to an unusual age, but how their immune systems were different. They had elevated inflammatory markers. Their baseline levels of IL-6, TNF-α, and CRP — the circulating proteins that signal tissue inflammation — were higher than younger adults. And yet they were extraordinarily healthy. They had reconciled, somehow, with an inflammatory burden that in most people would be associated with disease.7 min readImmune modulationInflammation resolution — what's supposed to happen after the inflammatory responseYou cut your finger and it swells. Redness, warmth, pain, swelling — the four classical signs of inflammation, described by the Roman physician Celsus two thousand years ago. Three days later the swelling is gone, the pain is gone, the skin is repairing, and life continues. This outcome is so routine we don't think of it as biology. It is, in fact, extraordinarily sophisticated biology, and for most of the twentieth century, medicine got a fundamental part of it wrong.6 min readMetabolic healthInsulin signaling and aging — from C. elegans to human metabolic diseaseIn 1993, a developmental biologist at the University of California San Francisco named Cynthia Kenyon made an observation that should have seemed impossible. She mutated a single gene in a millimeter-long nematode worm called Caenorhabditis elegans, a creature with a normal lifespan of roughly three weeks, and the worm lived twice as long. Not marginally longer. Twice as long. The gene was daf-2, the worm's equivalent of the insulin and IGF-1 receptor, and the mutation reduced its activity. The worm didn't just survive longer — it remained active and youthful longer, compressing its period of deterioration rather than extending it. Kenyon later described the moment as the discovery that aging was subject to genetic regulation, not merely the inevitable accumulation of wear. The implication was enormous: if a single signaling pathway could gate the lifespan of an organism, then aging was not a passive process. It was regulated. And what is regulated can, in principle, be intervened upon.7 min readAnti-aging and cellular healthAltered intercellular communication — how the body's cells stop talking clearlyIn 1956, a Cornell researcher named Clive McCay did something that sounds more like gothic fiction than gerontology: he surgically joined the bodies of an old rat and a young rat so that they shared a single bloodstream. Skin was sutured to skin, the two circulatory systems grew together, and for weeks the pair lived as one fused organism. When McCay examined the old animals afterward, their bones looked younger and denser than those of age-matched rats that had not been joined. The technique was called parabiosis, and the result hinted at something strange and important — that whatever ages a body is carried, at least in part, in the blood, and that the blood of the young carries something else. The experiment was crude, the animals suffered, and the field largely set it aside for half a century. Then, in the 2000s, it came roaring back.8 min readAnti-aging and cellular healthKlotho — the longevity protein and the cognitive aging connectionThe mouse looked old at three months. Not sickly in the way of a diseased animal — old, in the way of an animal whose systems had outpaced their design envelope. Muscle wasting. Skin atrophy. Vascular calcification. Emphysema-like lung changes. Hearing loss. Infertility. Osteoporosis. Cognitive decline. Death, typically before the animal reached two months of age when the phenotype was fully penetrant. Makoto Kuro-o, working at the National Institute of Neuroscience in Tokyo in 1997, had been doing conventional insertional mutagenesis screens — randomly disrupting genes in mice to see what happened — when he produced a mouse that had accidentally become a model of premature aging. He named the disrupted gene after the Greek Fate who spins the thread of life: Klotho.5 min readCognitive supportThe kynurenine pathway — how chronic inflammation affects cognition and moodYou come down with a serious infection — flu, pneumonia, something that puts you in bed for a week. What nobody prepares you for is the cognitive and emotional texture of the illness: the flat affect, the inability to concentrate, the deep fatigue that feels different from ordinary tiredness, the mood that drops in ways a headache alone can't explain. You've been told this is your immune system fighting the infection. What you haven't been told is that a significant portion of what you're experiencing in your brain is a direct downstream consequence of what the immune system is doing to a single amino acid.6 min readImmune modulationMast cells, MCAS, and the peptides explored for themYou eat the salad and your face flushes. Not every time — sometimes. The wine does it too, except on the nights it doesn't. You walk through the perfume aisle at a department store and a headache arrives within minutes, then the brain fog, then a fatigue that feels strangely disproportionate to what just happened. Your gut cycles through bloating, cramping, and diarrhea without any pattern a gastroenterologist can pin to something specific. The allergy tests come back negative. The allergist says you're not allergic. And yet.10 min readImmune modulationThe microbiome and peptides — where the gut bacteria meet the signaling moleculesThe patient had been through three rounds of antibiotics in two years — a sinus infection, then a skin infection, then a dental procedure that required prophylaxis. Each time the antibiotics worked. Each time, afterward, something shifted in the gut. The digestion that had always been unremarkable became unpredictable. The immune system that had always been quiet developed a new habit of overreacting. The energy, mood, and sleep quality that nobody associates with gut health began varying in ways that felt random but weren't. Nobody mentioned that the gut would need to be rebuilt.12 min readAnti-aging and cellular healthMicroRNAs — the tiny regulators of aging biologyIn 1993, a graduate student at Harvard named Rosalind Lee was studying a mutant strain of the nematode worm Caenorhabditis elegans that had been puzzling researchers for years. The worm had a defect in timing — its larval cells kept cycling as if they didn't know what developmental stage they were in. The responsible gene, lin-4, had been mapped but didn't code for any protein. That was the strange part. Most of molecular biology at the time assumed that if a gene mattered, it made a protein. Lin-4 didn't. What Lee and her mentor Victor Ambros found instead was that lin-4 produced a tiny RNA molecule — only twenty-two nucleotides long — that bound to the messenger RNA of another gene called lin-14 and suppressed its translation. The gene was writing instructions in RNA that silenced other instructions. It was regulation all the way down, and in a form nobody had been looking for.8 min readMitochondrial healthMitochondrial biogenesis — how cells build more power plants, and why it fades with ageMitochondria were not always part of us. The leading account of their origin, championed and made rigorous by the biologist Lynn Margulis in the late 1960s against considerable resistance, is that more than a billion years ago a free-living bacterium was engulfed by a larger cell and, instead of being digested, struck a bargain. The bacterium supplied energy; the host supplied shelter and raw materials. Over deep time the guest became a permanent resident, surrendering most of its genome to the host nucleus but keeping a small loop of its own DNA — which mitochondria carry to this day. This endosymbiotic event is arguably the most consequential merger in the history of life, because the energy it unlocked made complex, large-celled organisms possible. Every breath you take feeds these descendants of an ancient bacterium, and the question of how a cell decides to build more of them sits at the center of modern metabolic and longevity science.8 min readAnti-aging and cellular healthThe mTOR / autophagy axis — what it is and what peptides nudge itIn 1964, a Canadian research expedition to Easter Island — Rapa Nui in the Polynesian language — collected soil samples from the island's volcanic terrain with no particular expectation of what they'd find. Years later, a microbiologist named Suren Sehgal working at Ayerst Pharmaceuticals discovered in those samples a bacterium, Streptomyces hygroscopicus, that produced an unusual compound with antifungal activity. He named the compound rapamycin, after the island. Sehgal kept the project alive through corporate reorganizations, famously storing vials of rapamycin in his own home freezer when the program was nearly shut down. His instinct that the molecule was important proved correct, though neither he nor anyone else in 1972 fully understood why.7 min readCognitive supportNeuroplasticity — what the brain actually does throughout lifeIn the 1960s, a neuroscientist named Michael Merzenich was doing something that most of his colleagues thought was pointless. He was mapping the cortex of monkeys — painstakingly recording which cortical neurons fired in response to stimulation of different fingers — and then watching what happened to those maps when he severed the nerve to one finger. The expectation, consistent with the dominant model of the adult brain, was that the cortical region representing the lost finger would go dark. Fall silent. Become an island of unused tissue. What he found instead was that within weeks, the surrounding finger representations had expanded into that territory. The brain had remapped itself. The adult brain was not fixed. It was actively reorganizing in response to peripheral input, and the reorganization happened at a scale and speed that the fixed-architecture model couldn't accommodate.8 min readImmune modulationThe NLRP3 inflammasome — the molecular trigger for sterile inflammation in agingGout has been documented since the time of Hippocrates. It was called the disease of kings because it appeared disproportionately in wealthy men who ate meat and drank wine, and for most of medical history its mechanism was unknown — the joint swells, turns red, becomes exquisitely painful at the slightest touch, and then, after days, resolves. No infection explains it. No visible injury. The inflammation appears, peaks, and subsides as if triggered by something invisible.11 min readAnti-aging and cellular healthNutrient sensing — the four pathways that decide between growth and longevityIn the early 1990s, on the remote Pacific island of Rapa Nui — Easter Island — researchers studying a soil bacterium called Streptomyces hygroscopicus isolated a compound the bacterium used to suppress competing fungi. They named it after the island: rapamycin. For years it was developed as an antifungal, then as an immunosuppressant to prevent organ-transplant rejection. Only later, when biologists traced exactly how it worked, did they find that rapamycin acts on a single protein so central to how cells decide whether to grow that they named the protein after the drug: the mechanistic target of rapamycin, mTOR. That a fungus-fighting molecule from an island soil bacterium turned out to be a key that fits one of the master switches of cellular aging is one of the stranger origin stories in biology — and it opens directly onto the question of how cells know whether it is time to grow or time to endure.7 min readOrigins and discoveryHow peptides became a drug category — from insulin to GLP-1, one hundred years of peptide pharmacologyIt is January 11, 1922, and a fourteen-year-old boy named Leonard Thompson is lying in a Toronto hospital bed. He has had type 1 diabetes for two years. He weighs sixty-five pounds. His blood sugar is five hundred milligrams per deciliter. He has been on a severe starvation diet — the only management available — which is buying him weeks. Frederick Banting and Charles Best inject him with a partially purified extract from canine pancreatic tissue. He goes into anaphylactic shock. The extract is crude, contaminated, and the dose is poorly characterized. They stop. They spend the next twelve days refining the preparation with a biochemist named James Collip. On January 23, they inject Thompson again. Within twenty-four hours his blood sugar drops to normal. The boy who was starving in a Toronto hospital lives for another thirteen years before dying, not from diabetes, of pneumonia. In those thirteen years he is the first human being to survive a disease that had been uniformly fatal in juveniles since antiquity.12 min readAnti-aging and cellular healthProteostasis — the quality-control network that keeps proteins from killing cellsA protein begins life as a featureless string. The ribosome reads the genetic code and links amino acids one by one into a linear chain, and that chain, in itself, does nothing — it is a sentence with no meaning until it folds. Folding is where a protein becomes a machine: the chain collapses, in milliseconds to seconds, into a precise three-dimensional shape, and that shape is the function. An enzyme's pocket that grips its target, an antibody's arms that clamp an antigen, the channel in a membrane protein that lets ions through — all of it is folded geometry. Christian Anfinsen won a Nobel Prize for showing, in the 1960s, that a protein's sequence contains the instructions for its own folded shape. But Anfinsen worked with purified proteins in a test tube. Inside a living cell, folding has to happen in a chaotic, crowded environment, at speed, on tens of thousands of different proteins at once, with new chains pouring off ribosomes every second and old proteins constantly being damaged. The fact that this works at all, reliably, for decades, is one of the quiet miracles of cellular life, and the system that makes it work is called proteostasis.8 min readAnti-aging and cellular healthSirtuins — the longevity proteins and what they actually doIn the late 1990s, a yeast cell in Leonard Guarente's lab at MIT quietly upended the assumption that lifespan was a fixed parameter. The gene in question was Sir2 — Silent Information Regulator 2 — and when researchers added extra copies of it to yeast, the cells lived longer. When they deleted it, the cells died sooner. Nobody had expected a single gene to move the lifespan needle in either direction. The question the experiment opened wasn't just "what does Sir2 do" but something more unsettling: if a gene could regulate how long a cell lives, what exactly is the machinery of aging, and how close to the surface is it?12 min readAnti-aging and cellular healthStem cell exhaustion — why the body's repair reserve runs downIn 1961, two researchers at the Ontario Cancer Institute, Ernest McCulloch and James Till, were trying to measure radiation sensitivity in mouse bone marrow. They injected marrow cells into irradiated mice and noticed something they had not been looking for: lumps growing on the spleens of the recipients, one lump for roughly every so many cells injected. Each lump turned out to be a colony of blood cells, and each colony, they eventually proved, had grown from a single cell that could both copy itself and produce every type of blood cell. They had stumbled onto the first quantitative proof that stem cells exist. The discovery reframed how biologists thought about tissue: a body is not a fixed set of cells that you are issued at birth and slowly lose, but a system continually rebuilt from small reserves of cells held back for exactly that purpose.8 min readImmune modulationThe thymus — the immune organ that shrinks before everything elseThere's a small organ behind your sternum, roughly the size of a walnut, that most people have never thought about and that your immune system depends on in ways that don't become obvious until the damage is done. The thymus doesn't appear on the list of organs people worry about. It doesn't have a celebrity disease. There's no thymus awareness month. But if you're asking why immunity tends to fray so predictably with age — why vaccines become less effective, why novel infections become harder to handle, why certain autoimmune conditions increase in older populations — the thymus is where the story begins.11 min readAnti-aging and cellular healthThe unfolded protein response — how the cell handles its own folding crisesIn the late 1980s, a cell biologist named Mary-Jane Gething and her colleague Joe Sambrook were studying how a viral protein folds inside cells when they noticed something that did not fit. When they forced cells to accumulate a misfolded protein in a compartment called the endoplasmic reticulum, the cells responded by ramping up production of a particular set of helper proteins — as if the cell had detected the folding problem and was calling for reinforcements. The cell, in other words, was monitoring the quality of its own protein folding and reacting when that quality slipped. Over the following decade, laboratories led by researchers including Peter Walter and Kazutoshi Mori would work out the machinery behind that reaction and give it a name: the unfolded protein response. It turned out to be one of the most important quality-control systems a cell possesses, and its failure runs through some of the most feared diseases in medicine.8 min readCognitive supportThe vagus nerve, deeper — afferents, the inflammatory reflex, and the polyvagal debateIn 1998, an immunologist named Kevin Tracey was testing an experimental anti-inflammatory drug in the brains of rats, expecting it to act only inside the skull. Instead, when he injected the compound into the brain, inflammation dropped throughout the body, far from the injection site, and faster than any blood-borne signal could have traveled. The result made no sense under the prevailing model, in which inflammation was governed by molecules diffusing through the bloodstream. Tracey reasoned that something faster than chemistry must be carrying the message — something electrical. He cut the vagus nerve in the rats, repeated the experiment, and the anti-inflammatory effect vanished. The brain had been using the vagus nerve as a wire to switch off inflammation in the body. That single experiment opened a field, and it is the right place to begin a deeper look at a nerve most people think they already understand.8 min readCognitive supportThe vagus nerve — the wandering nerve that connects everythingIn 1921, a German pharmacologist named Otto Loewi woke from a dream, scrawled something on a notepad, went back to sleep, and woke again to find his own handwriting unreadable. The next night the dream returned and this time he went immediately to his laboratory. He took two frog hearts, kept both beating in saline solution, and stimulated the vagus nerve of one. That heart slowed down. He then transferred the saline fluid to the second heart and it also slowed — without any nerve stimulation at all. Something chemical had been released by vagal stimulation. That chemical was acetylcholine, the first neurotransmitter identified in the human body. The experiment won Loewi the Nobel Prize in 1936, and it established, at the cellular level, what the vagus nerve actually does: it releases a molecule that slows the heart.11 min read